Saturday, July 11, 2026

Drug profile · INN

tasonermin

tasonermin (BEROMUN) is a unknown.

EMA: approved Antineoplastic and immunomodulating agents (L03) L03AX11
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — tasonermin
Class
Antineoplastic and immunomodulating agents (L03)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

tasonermin (BEROMUN) is a unknown.

Key facts

INN tasonermin
Brand BEROMUN
Mechanism Unknown
Therapeutic class Antineoplastic and immunomodulating agents (L03)
ATC code L03AX11

Mechanism of action

Unknown

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. abiraterone acetate Antineoplastic and immunomodulating agents (L02)
  2. anagrelide Antineoplastic and immunomodulating agents (L01)
  3. apremilast Antineoplastic and immunomodulating agents (L04)
  4. arsenic trioxide Antineoplastic and immunomodulating agents (L01)
  5. axitinib Antineoplastic and immunomodulating agents (L01)
  6. azacitidine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is tasonermin?

tasonermin (BEROMUN) is a unknown.

What is the brand name for tasonermin?

BEROMUN is a marketed brand name for tasonermin. Check FDA Drugs@FDA for the current US label holder and prescribing information.